tiprankstipranks
ChromaDex Reports Strong Q3 2024 Financial Results
PremiumCompany AnnouncementsChromaDex Reports Strong Q3 2024 Financial Results
3M ago
Chromadex Reports Strong Q3 2024 with 31% Sales Increase
Premium
Company Announcements
Chromadex Reports Strong Q3 2024 with 31% Sales Increase
3M ago
ChromaDex reports Q3 EPS 2c, consensus 0c
Premium
The Fly
ChromaDex reports Q3 EPS 2c, consensus 0c
3M ago
ChromaDex expands pharmaceutical-grade Niagen IV, injection offerings
PremiumThe FlyChromaDex expands pharmaceutical-grade Niagen IV, injection offerings
4M ago
ChromaDex  broadens NAD+ precursor intellectual property portfolio with patent
Premium
The Fly
ChromaDex broadens NAD+ precursor intellectual property portfolio with patent
5M ago
ChromaDex management to meet virtually with Roth MKM
Premium
The Fly
ChromaDex management to meet virtually with Roth MKM
5M ago
ChromaDex launches Niagen+ NAD+ Test Kit available exclusively to HCPs
PremiumThe FlyChromaDex launches Niagen+ NAD+ Test Kit available exclusively to HCPs
6M ago
ChromaDex announces appointment of Carlos Lopez as  General Counsel
Premium
The Fly
ChromaDex announces appointment of Carlos Lopez as General Counsel
6M ago
ChromaDex to debut pharmaceutical-grade Niagen at clinics in August
Premium
The Fly
ChromaDex to debut pharmaceutical-grade Niagen at clinics in August
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100